chr2-1165604-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_018968.4(SNTG2):c.468G>A(p.Arg156=) variant causes a synonymous change. The variant allele was found at a frequency of 0.00177 in 1,613,060 control chromosomes in the GnomAD database, including 48 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0092 ( 27 hom., cov: 32)
Exomes 𝑓: 0.0010 ( 21 hom. )
Consequence
SNTG2
NM_018968.4 synonymous
NM_018968.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.91
Genes affected
SNTG2 (HGNC:13741): (syntrophin gamma 2) This gene encodes a protein belonging to the syntrophin family. Syntrophins are cytoplasmic peripheral membrane proteins that bind to components of mechanosenstive sodium channels and the extreme carboxy-terminal domain of dystrophin and dystrophin-related proteins. The PDZ domain of this protein product interacts with a protein component of a mechanosensitive sodium channel that affects channel gating. Absence or reduction of this protein product has been associated with Duchenne muscular dystrophy. There is evidence of alternative splicing yet the full-length nature of these variants has not been described. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 2-1165604-G-A is Benign according to our data. Variant chr2-1165604-G-A is described in ClinVar as [Benign]. Clinvar id is 767778.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00917 (1397/152282) while in subpopulation AFR AF= 0.0318 (1322/41538). AF 95% confidence interval is 0.0304. There are 27 homozygotes in gnomad4. There are 622 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 27 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SNTG2 | NM_018968.4 | c.468G>A | p.Arg156= | synonymous_variant | 7/17 | ENST00000308624.10 | NP_061841.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SNTG2 | ENST00000308624.10 | c.468G>A | p.Arg156= | synonymous_variant | 7/17 | 1 | NM_018968.4 | ENSP00000311837 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00914 AC: 1391AN: 152164Hom.: 27 Cov.: 32
GnomAD3 genomes
AF:
AC:
1391
AN:
152164
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00261 AC: 647AN: 248114Hom.: 7 AF XY: 0.00207 AC XY: 279AN XY: 134594
GnomAD3 exomes
AF:
AC:
647
AN:
248114
Hom.:
AF XY:
AC XY:
279
AN XY:
134594
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000998 AC: 1458AN: 1460778Hom.: 21 Cov.: 30 AF XY: 0.000900 AC XY: 654AN XY: 726616
GnomAD4 exome
AF:
AC:
1458
AN:
1460778
Hom.:
Cov.:
30
AF XY:
AC XY:
654
AN XY:
726616
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00917 AC: 1397AN: 152282Hom.: 27 Cov.: 32 AF XY: 0.00835 AC XY: 622AN XY: 74450
GnomAD4 genome
AF:
AC:
1397
AN:
152282
Hom.:
Cov.:
32
AF XY:
AC XY:
622
AN XY:
74450
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at